TXNDC9 and colorectal carcinoma: Overall, ICA exerted its primary effects on CRC cells by modulating the interaction between HSP90 and TXNDC9, consequently reducing TXNDC9 protein levels, promoting autophagic cell death, enhancing apoptosis, and ultimately achieving its antitumor effects.